The bill authorizes the Attorney General to award grants to States, territories, and localities to support improved data and surveillance on opioid-related overdoses. This includes activities to enhance postmortem toxicology testing, data linkage across systems, electronic death reporting, and the comprehensiveness of data on fatal and nonfatal overdoses.
It also creates targeted law enforcement and forensic grants to train officers to identify overdoses, upgrade drug tracing and forensic laboratory systems, and support data reporting to the National Forensic Laboratory Information System (NFLIS), with a requirement that grantees report to NFLIS. The act adds training provisions for federal and local law enforcement on coordination for tracking drug-related activity, and amends COPS funding to include containment resources to prevent secondary fentanyl exposure.
In addition, the bill directs the DEA to develop uniform NFLIS data standards for purity, formulation, and weight, and to include a dedicated budget line item for the Fentanyl Signature Profiling Program, signaling an emphasis on standardized data and advanced drug analysis.
At a Glance
What It Does
The Attorney General may award grants to states, territories, and localities to fund improved data and surveillance on opioid overdoses, including postmortem toxicology, cross‑system data linkage, electronic death reporting, and more comprehensive overdose data.
Who It Affects
State and local health departments, forensic laboratories, NFLIS data users, and law enforcement in communities with high overdose rates.
Why It Matters
Standardized, richer data across jurisdictions enables faster public health responses and more precise enforcement strategies, while aligning federal resources with data-driven decision making.
More articles like this one.
A weekly email with all the latest developments on this topic.
What This Bill Actually Does
The bill creates a grant-based framework to shore up the data infrastructure around opioid overdoses. By funding state and local health departments, it aims to improve how overdose events are recorded, linked across systems, and reported electronically.
The intent is to produce a clearer, more complete picture of when and where overdoses occur, which can guide both prevention and response efforts.
A parallel provision funnels resources to law enforcement and forensic laboratories. In high-overdose communities, grants would support training to recognize overdoses, upgrade drug-tracing and laboratory data pipelines to NFLIS, and strengthen the ability to share timely, standardized data.
The bill also expands federal training efforts to help agencies coordinate with state and federal partners on drug tracing and activity in the supply chain and darknet space. Importantly, it requires that grant funds used for enforcement-related work must still feed into NFLIS reporting, anchoring enforcement data in a national database.On data standards, the act asks the DEA to establish uniform NFLIS reporting standards for purity, formulation, and weight.
This standardization aims to improve cross-state comparability without imposing new obligations on local labs. Finally, the bill allocates a dedicated budget line item for the Fentanyl Signature Profiling Program as part of DEA funding, signaling a move toward more granular, evidence-based profiling of illicit fentanyl.
Taken together, the bill seeks to connect health data with enforcement data in a way that should sharpen policy responses to the overdose crisis.
The Five Things You Need to Know
The AG may award grants to states, territories, and localities to fund improved opioid overdose data and surveillance.
Grants support postmortem toxicology testing, data linkage, and electronic death reporting to improve data comprehensiveness.
Grants are available to law enforcement and forensic labs to enhance overdose identification, drug tracing, and NFLIS reporting.
DEA must develop uniform NFLIS data standards for purity, formulation, and weight to enable cross-jurisdiction comparisons.
DEA must include a specific budget line item for the Fentanyl Signature Profiling Program in its annual funding request.
Section-by-Section Breakdown
Every bill we cover gets an analysis of its key sections.
Grants for overdose data accuracy and surveillance
This section authorizes the Attorney General to award grants to states, territories, and localities to support improved data and surveillance on opioid-related overdoses. It covers activities such as expanding postmortem toxicology testing, establishing data linkage across disparate systems (health, vital records, law enforcement), improving electronic death reporting, and broadening the comprehensiveness of data on both fatal and nonfatal overdoses. The goal is to produce higher-quality, more timely data to inform public health and enforcement responses.
Law enforcement and forensic grants; NFLIS reporting
Section 3 creates grants to local law enforcement agencies and forensic laboratories in communities with high overdose rates to (1) train officers to identify overdoses, (2) upgrade tracing and processing capabilities in labs to feed timely, accurate, and standard data to NFLIS, and (3) train to better trace criminals through the darknet. It also requires that funds under this section be used only for programs that submit overdose data to NFLIS. The section includes directives for Federal Law Enforcement Training Centers to coordinate with state and local partners on tracking drug-related activity, and amends the COPS program to add containment device resources to prevent secondary exposure to fentanyl for first responders.
Uniform NFLIS data standards
The DEA shall develop uniform reporting standards for inputting data into NFLIS with respect to drug purity, formulation, and weight to enable better cross-jurisdiction comparison and interagency data sharing. The subsection clarifies that nothing in this section should create new or increased obligations or reporting requirements on state or local laboratories, preserving local flexibility while seeking consistency in data elements.
Fentanyl profiling funding
The DEA must include in its annual budget a specific line item for the level of funding necessary to operate the Fentanyl Signature Profiling Program. This directs congressional attention and resources to advanced drug profiling capabilities, aligning enforcement capabilities with the improved data ecosystem described in earlier sections.
This bill is one of many.
Codify tracks hundreds of bills on Government across all five countries.
Explore Government in Codify Search →Who Benefits and Who Bears the Cost
Every bill creates winners and losers. Here's who stands to gain and who bears the cost.
Who Benefits
- State and local health departments gain access to targeted funding to modernize overdose data collection, which supports quicker, more informed public health actions.
- Forensic laboratories and NFLIS users benefit from standardized data inputs and faster, more reliable reporting, improving national data coherence.
- Law enforcement agencies in high-overdose communities receive training and upgraded tools for overdose identification and drug tracing.
- Researchers and policymakers gain more complete, cross-jurisdiction data to inform policy design and evaluation.
- DEA and ONDCP obtain richer data streams and a clearer mandate for analytics like fentanyl profiling.
Who Bears the Cost
- State and local governments must budget and implement new data systems and reporting practices.
- Forensic laboratories may incur capital and personnel costs to meet enhanced data standards and reporting demands.
- Law enforcement agencies face training costs and procurement for tracing infrastructure and data sharing.
- Federal agencies must fund and administer new standards-development efforts and the profiling program.
- Taxpayers may bear broader costs associated with expanded data collection and program administration.
Key Issues
The Core Tension
The central tension is between the public health benefits of richer, standardized overdose data and the practical costs and privacy concerns of expanding data collection and reporting across many jurisdictions.
The bill’s emphasis on expanding data collection and cross-agency data sharing raises tensions between public health benefits and potential burdens on local jurisdictions. While standardization can improve national visibility into overdoses and facilitate coordinated responses, it also risks increasing reporting obligations for state and local labs, which could strain limited resources.
The requirement that enforcement funds feed into NFLIS helps ensure data is centralized, but it also consolidates reporting workflows that may require significant upfront investments. The expansion of training and the darknet tracing focus highlights a dual desire to improve detection and strengthen interagency coordination, which can be resource-intensive and complex to execute across diverse jurisdictions.
A core implementation challenge will be balancing, on the one hand, richer, more actionable data and, on the other hand, the administrative burden and privacy considerations that accompany expanded data collection and sharing. In particular, uniform standards for precision in drug data (purity, weight) must be adopted without creating new mandatory obligations for local labs, which could otherwise hamper participation or timeliness of data.
The deregulatory note in subsection 4(b) aims to preserve state flexibility, but the overall suite of provisions creates a more centralized data ecosystem that requires careful governance and ongoing funding to remain effective.
Try it yourself.
Ask a question in plain English, or pick a topic below. Results in seconds.